Ennovance is a private family office headquartered in Philadelphia with a global presence across North America, Europe, and Asia. The firm focuses on alternative asset investments, particularly in the chemicals, specialty materials, and healthcare-related services sectors. Through Ennovance Capital, it engages in buyouts, growth capital, and special situations, applying an operational approach centered on strategic growth initiatives and performance improvement. Backed by a senior management team with over 130 years of experience in Fortune 100 chemical companies, Ennovance collaborates closely with portfolio company management to drive sustainable long-term value. With a stable capital base and a broad global network, the firm offers flexible deal structures and can invest up to $200 million per portfolio company—making it a strong partner for entrepreneurs, corporations, and fund managers pursuing innovation and growth in their industries.